SynthesisProstate cancer and prostatic diseases2013
Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments.
Synthesis in Prostate cancer and prostatic diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.
- Assessing cognition in people with severe mental disorders in low- and middle-income countries: a systematic review of assessment measures.Social psychiatry and psychiatric epidemiology · 2022Pooled it
- Unrecognized sexual dysfunction in gay and bisexual men after prostate cancer treatment: the antecedents and impact of anodyspareunia.The journal of sexual medicine · 2023Trial
- Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer.World journal of urology · 2022Trial
- Pain and Loss of Pleasure in Receptive Anal Sex for Gay and Bisexual Men following Prostate Cancer Treatment: Results from theJournal of sex research · 2022Article
- Implementation of patient-reported outcome measures into health care for men with localized prostate cancer.Nature reviews. Urology · 2022Review
- Clinical use of expanded prostate cancer index composite-based health-related quality of life outcomes after robot-assisted radical prostatectomy for localized prostate cancer.Prostate international · 2022Article
- The ALERT-B questionnaire: A screening tool for the detection of gastroenterological late effects after radiotherapy for prostate cancer.Clinical and translational radiation oncology · 2020Article
- Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers.Current oncology reports · 2020Review
- Article
- Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian population.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2017Article
- Symptoms and Impacts in Non-Metastatic Castration-Resistant Prostate Cancer: Qualitative Study Findings.The patient · 2017Article
- Key issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS).BMJ supportive & palliative care · 2017Article
- Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study.BMJ open · 2016Article
- The internal and external responsiveness of Functional Assessment of Cancer Therapy-Prostate (FACT-P) and Short Form-12 Health Survey version 2 (SF-12 v2) in patients with prostate cancer.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2016Article
- Oncology Section EDGE Task Force on Prostate Cancer: A Systematic Review of Outcome Measures for Health-Related Quality of Life.Rehabilitation oncology (American Physical Therapy Association. Oncology Section) · 2016Article
- Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate's egg.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2015Article
- Article
- Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS).Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2014Article
- Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2014Article
- Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.The Journal of urology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is critical for prostate cancer researchers and clinicians to have access to comprehensive, sensitive and simple-to-use symptom measures that allow them to understand and quantify the subjective patient experience. The purpose of the current review is to provide a comprehensive review, detailed tool descriptions and objectively defined quality criteria to facilitate tool choices for patients with localized prostate cancer. Using a systematic web-based literature search, we found n=29 prostate symptom measures described in n=35 validation studies. To be recommended, tools needed to meet four criteria: broad domain coverage, ability to differentiate objective and subjective experience, good internal consistency and validation in at least two populations and/or having achieved two types of validations. Of the 29 tools reviewed, n=7 meet our criteria for recommendation, and three in particular (the EPIC-26 (Expanded Prostate Cancer Index Composite)-26, PC-QOL (Prostate Cancer-Quality of Life) and the UCLA-PCI (UCLA Prostate Cancer Index)) showed the strongest psychometrics. There is a reasonable number of measures to choose from that meet criteria for good psychometrics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.